51
Participants
Start Date
January 31, 2010
Primary Completion Date
November 30, 2010
Study Completion Date
November 30, 2010
misoprostol
One vaginal insert containing 100, 200, 400, 800, 1200, 1600 mcg misoprostol administered intravaginally one time and remain in place for 18 - 24 hours prior to the hysteroscopy procedure. An adaptive design will be used to determine whether to escalate or reduce the dose, starting with MVPI 400 mcg.
placebo
placebo
Lyndhurst Gynecologic Associates, Winston-Salem
Precision Trials, Phoenix
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY